+33(0)1 42 54 60 64 |

contact@welcomeurope.com

Login

EU4H – Monitor and strengthen the implementation of innovative approaches to prostate, lung and gastric cancer screening at Union level – 2022

EU4H - Monitor and strengthen the implementation of innovative approaches to prostate, lung and gastric cancer screening at Union level, aiming at providing Member States with evidence-based knowledge to be transferred to further design, plan, and implement prostate, lung, and gastric cancer screenings.

2022-05-24
30 million euro
Close

Appeal framework

Institution European Commission
Sectors Health Research & Innovation
Beneficiaries All beneficiaries Association & NGO Research centre & university Training organisation & school
Regions Developing countries, European Economic Area, European Union
Details
  • EU Member States (including overseas countries and territories linked to it (OCTs))
  • Eligible non-EU countries : listed EEA countries and countries associated to the EU4Health Programme or countries which are in ongoing negotiations for an association agreement and where the agreement enters into force before the deadline for submission

 

Content reserved for subscribers

Register for free to access the content

Free access to all information

Priorities and funded actions

Objective

To provide Member States with evidence-based knowledge to be transferred to further design, plan, and implement prostate, lung, and gastric cancer screenings

Priorities

  • Priority 1: optimisation of knowledge transfer, a better understanding of the needs, and the design, planning and development of possible options for future implementation of targeted screening on prostate, lung, and gastric cancers
  • Priority 2: initiatives to fill the existing gaps in knowledge and to fine-tune and improve the Member States’ approaches to the early detection of prostate, lung, and gastric cancer
  • Priority 3: develop and roll-out pilot projects through pan-European cooperation, with a special focus on addressing questions that are still open, including on cost-benefit and optimal benefit-harm balance and potential impact on health inequality of prostate, lung and gastric cancer screening programmes including the identification of appropriate financing mechanisms

Among financed actions

  • Needs assessment of Member States, taking into account the different epidemiology and populations at risk for lung, prostate and gastric cancers
  • Periodical information on benefit-harm balance and cost-effectiveness of the screenings
  • The design, planning and implementation of at least two pilot projects per type of cancer, with the objective of assessing the concrete feasibility of the screenings, fulfilling the requirements of national or regional health authorities
  • At least three highly visible conferences targeting all three types of cancers

Additional information

  • This call for proposals is an open call for proposals
  • Initial duration of the action: between 12 and 36 months

Eligibility

  • Be legal entities (public or private bodies)
  • Be established in one of the eligible countries
  • Proposals by a single applicant are also eligible
Financement
  • Total amount of the call: 107,3 million euro
  • Total budget of the topic “Monitor and strengthen the implementation of innovative approaches to prostate, lung and gastric cancer screening at Union level”: 30 million euro
    • Sub-topic 1 “CR-g-22-09.01”: 10 million euro
    • Sub-topic 2 “CR-g-22-09.02”: 10 million euro
    • Sub-topic 3 “CR-g-22-09.03”: 10 million euro
  • Co-financing rate: up to 60% of the total eligible costs; or up to 80% if your project is of “exceptional utility”

 

Test your eligibility

Need help with your public financing ?

Similar news

10 February 2021

A 4 billion euro plan to fight against cancer

Lire l'article

21 February 2022

16-20 May 2022: European Public Health Week

Lire l'article